Publications

Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

 65
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

Tags:

Previous Article

Driver of cardiac injury after coronary microembolization

Next Article

How glioblastoma tumors dodge chemotherapy

Related Posts

The HIF axes in cancer: angiogenesis, metabolism, and immune-modulation

The HIF axes in cancer: angiogenesis, metabolism, and i...

 197

Phage therapy in oncology: opportunities for cancer prevention and treatment

Phage therapy in oncology: opportunities for cancer pre...

 40

Oligomeric HIV-1 integrase structures reveal functional plasticity for intasome assembly and RNA binding

Oligomeric HIV-1 integrase structures reveal functional...

 81